Ifrah Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.46M	Sell	3,277 -120	-4%	-$56K	0.39%	51
2025 Q4	$1.54M	Sell	3,397 -79	-2%	-$34.1K	0.4%	50
2025 Q3	$1.36M	Sell	3,476 -25	-0.7%	-$10.4K	0.35%	54
2025 Q2	$1.56M	Sell	3,501 -44	-1%	-$20.3K	0.43%	48
2025 Q1	$1.72M	Sell	3,545 -273	-7%	-$127K	0.49%	45
2024 Q4	$1.54M	Sell	3,818 -132	-3%	-$61.2K	0.42%	48
2024 Q3	$1.84M	Sell	3,950 -102	-3%	-$49K	0.5%	46
2024 Q2	$1.9M	Sell	4,052 -403	-9%	-$175K	0.54%	44
2024 Q1	$1.86M	Sell	4,455 -102	-2%	-$43.1K	0.52%	44
2023 Q4	$1.85M	Sell	4,557 -179	-4%	-$66.1K	0.54%	41
2023 Q3	$1.65M	Sell	4,736 -49	-1%	-$17.1K	0.51%	46
2023 Q2	$1.68M	Sell	4,785 -76	-2%	-$25.6K	0.51%	45
2023 Q1	$1.53M	Sell	4,861 -119	-2%	-$35.7K	0.49%	48
2022 Q4	$1.44M	Sell	4,980 -165	-3%	-$50.3K	0.47%	48
2022 Q3	$1.49M	Sell	5,145 -38	-0.7%	-$10.9K	0.51%	49
2022 Q2	$1.46M	Sell	5,183 -82	-2%	-$21.9K	0.47%	50
2022 Q1	$1.37M	Buy	5,265 +2,651	+101%	+$629K	0.39%	52
2021 Q4	$574K	Buy	+2,614	New	+$508K	0.15%	113